ST PHARM CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109,600 KRW | +15.49% |
|
+20.44% | +61.65% |
| 2023 | ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2021 | ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility | CI |
Evolution of the average Target Price on ST Pharm Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
cd7d2057ed8d9f2.LuMusJRFCXEZDD9fAeV4GMcBwUWf-1ESA8yS7Bpk2wI.SJUWhaYwSy5wYhIqNIYKSPROthOpqjZ7TPvHlCJdtVcYonf44BJCAik8WA~b30410059104d81766d1829e25078cef
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
109,600
KRW
Average target price
105,000
KRW
Spread / Average Target
-4.20%
High Price Target
140,000
KRW
Spread / Highest target
+27.74%
Low Price Target
100,000
KRW
Spread / Lowest Target
-8.76%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A237690 Stock
- Consensus ST Pharm Co.,Ltd.
